Ryan Bender

1.8k citations

39 papers · 1.2k indexed · h-index 19

Impact in

Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
Oncology top 5%
- Cutaneous Melanoma Detection and Management
- HER2/EGFR in Cancer Research

Papers in ⓘ

Toxicology 3
- Bioactive Compounds and Antitumor Agents 3
Cancer Research 13
- Cancer Genomics and Diagnostics 10
- Breast Cancer Treatment Studies 3

Co-authors: Neil Osheroff (8 shared papers)Zoran Gatalica (21 shared papers)Sherri Z. Millis (12 shared papers)R. Hunter Lindsey (3 shared papers)Semir Vranić (7 shared papers)Gargi D. Basu (9 shared papers)Andreas Voß (3 shared papers)Jennifer A. Wargo (1 shared paper)
Journals: Journal of Clinical Oncology (11 papers)Biochemistry (5 papers)Oncotarget (4 papers)Human Pathology (2 papers)Chemical Research in Toxicology (2 papers)
Partner nations: United States Bosnia and Herzegovina Italy

In The Last Decade

Ryan Bender

39 papers receiving 1.1k citations

Peers

Countries citing papers authored by Ryan Bender

Since Specialization

Citations

This map shows the geographic impact of Ryan Bender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Bender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Bender more than expected).

Fields of papers citing papers by Ryan Bender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Bender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Bender. The network helps show where Ryan Bender may publish in the future.

Co-authors

The 25 scholars most cited alongside Ryan Bender, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ryan Bender Line = papers co-authored together Ryan Bender links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma Nature Medicine ·Lawrence N. Kwong, James C. Costello, Huiyun Liu, Shan Jiang, Timothy L. Helms, Aliete Langsdorf, David Jakubosky, Giannicola Genovese, Florian L. Müller, Joseph H. Jeong, Ryan Bender, Gerald C. Chu, Keith T. Flaherty, Jennifer A. Wargo, (unknown), Lynda Chin	2012	274
2	Molecular Profiling of Clear Cell Ovarian Cancers International Journal of Gynecological Cancer ·Michael Friedländer, Kenneth Russell, Sherri Z. Millis, Zoran Gatalica, Ryan Bender, Andreas Voß	2016	67
3	Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1 Oncotarget ·Zoran Gatalica, Nurija Bilalović, Juan Palazzo, Ryan Bender, Jeffrey Swensen, Sherri Z. Millis, Semir Vranić, Daniel D. Von Hoff, R.J. Arceci	2015	67
4	N-Acetyl-p-benzoquinone Imine, the Toxic Metabolite of Acetaminophen, Is a Topoisomerase II Poison Biochemistry ·Ryan Bender, R. Hunter Lindsey, D. Andrew Burden, Neil Osheroff	2004	59
5	Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: Analysis of 1806 cases Oncotarget ·Zoran Gatalica, Sherri Z. Millis, Semir Vranić, Ryan Bender, Gargi D. Basu, Andreas Voß, Daniel D. Von Hoff	2014	56
6	Topoisomerase II−Drug Interaction Domains: Identification of Substituents on Etoposide That Interact with the Enzyme Biochemistry ·Amy M. Wilstermann, Ryan Bender, Murrell Godfrey, Sungjo Choi, Clemens Anklin, David B. Berkowitz, Neil Osheroff, David E. Graves	2007	55
7	Molecular Profiling of Infiltrating Urothelial Carcinoma of Bladder and Nonbladder Origin Clinical Genitourinary Cancer ·Sherri Z. Millis, David Bryant, Gargi D. Basu, Ryan Bender, Semir Vranić, Zoran Gatalica, Nicholas J. Vogelzang	2014	53
8	Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers Journal of Molecular Diagnostics ·Wenhsiang Wen, Wangjuh Chen, Nick Xiao, Ryan Bender, Anatole Ghazalpour, Zheng Tan, Jeffrey Swensen, Sherri Z. Millis, Gargi D. Basu, Zoran Gatalica, Michael F. Press	2015	53
9	Polychlorinated Biphenyl Quinone Metabolites Poison Human Topoisomerase IIα: Altering Enzyme Function by Blocking the N-Terminal Protein Gate Biochemistry ·Ryan Bender, Hans‐Joachim Lehmler, Larry W. Robertson, Gabriele Ludewig, Neil Osheroff	2006	51
10	Individual and systemic/structural bias in child welfare decision making: Implications for children and families of color Children and Youth Services Review ·Keva M. Miller, Katharine Cahn, Ben Anderson-Nathe, Angela Cause, Ryan Bender	2013	49
11	Quinone-Induced Enhancement of DNA Cleavage by Human Topoisomerase IIα: Adduction of Cysteine Residues 392 and 405 Biochemistry ·Ryan Bender, Amy‐Joan L. Ham, Neil Osheroff	2007	49
12	Substituents on Etoposide That Interact with Human Topoisomerase IIα in the Binary Enzyme−Drug Complex: Contributions to Etoposide Binding and Activity Biochemistry ·Ryan Bender, Michael J. Jablonksy, Mohammad Shadid, Ian M. Romaine, Norma Dunlap, Clemens Anklin, David E. Graves, Neil Osheroff	2008	46
13	Effects of Benzene Metabolites on DNA Cleavage Mediated by Human Topoisomerase IIα: 1,4-Hydroquinone Is a Topoisomerase II Poison Chemical Research in Toxicology ·R. Hunter Lindsey, Ryan Bender, Neil Osheroff	2005	44
14	Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast Human Pathology ·Semir Vranić, Caterina Marchiò, Isabella Castellano, C. Botta, Maria Stella Scalzo, Ryan Bender, César Payán‐Gómez, Ludovica Verdun di Cantogno, Patrizia Gugliotta, Fabrizio Tondat, Paola Francia di Celle, Sara Mariani, Zoran Gatalica, Anna Sapino	2015	38
15	Stimulation of topoisomerase II-mediated DNA cleavage by benzene metabolites Chemico-Biological Interactions ·R. Hunter Lindsey, Ryan Bender, Neil Osheroff	2005	33
16	Identification of HRAS mutations and absence of GNAQ or GNA11 mutations in deep penetrating nevi Modern Pathology ·Ryan Bender, Matthew J. McGinniss, Paula Esmay, Elsa F. Velázquez, Julie D.R. Reimann	2013	30
17	Juxtaglomerular cell tumor: A morphological, immunohistochemical and genetic study of six cases Human Pathology ·Naoto Kuroda, Māris Sperga, Federico A. Monzon, Puay Hoon Tan, Anjula Thomas, Fredrik Petersson, Zoran Gatalica, Anatole Ghazalpour, Ryan Bender, Petr Grossmann, Michal Michal, Marián Švajdler, Zdenka Ovčak, Milan Hora, Ondřej Hes	2012	28
18	Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast Oncotarget ·Zoran Gatalica, Semir Vranić, Anatole Ghazalpour, Joanne Xiu, Idris Tolgay Ocal, J. McGill, Ryan Bender, Erin Discianno, Aaron Schlum, Souzan Sanati, Juan Palazzo, Sandeep K. Reddy, Barbara A. Pockaj	2015	24
19	Mutation of Cysteine Residue 455 to Alanine in Human Topoisomerase IIα Confers Hypersensitivity to Quinones: Enhancing DNA Scission by Closing the N-Terminal Protein Gate Chemical Research in Toxicology ·Ryan Bender, Neil Osheroff	2007	21
20	Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies Oncotarget ·Joanne Xiu, David Piccioni, Tiffany Juarez, Sandeep C. Pingle, Jethro Hu, Jeremy Rudnick, Karen Fink, David Spetzler, Todd Maney, Anatole Ghazalpour, Ryan Bender, Zoran Gatalica, Sandeep K. Reddy, Nader Sanai, Ahmed Idbaïh, Michael Glantz, Santosh Kesari	2016	18

About Ryan Bender

Ryan Bender is a scholar working on Toxicology, Cancer Research, Oncology, Dermatology and Pathology and Forensic Medicine, having authored 39 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (10 papers), Cancer therapeutics and mechanisms (8 papers), Colorectal Cancer Treatments and Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Breast Cancer Treatment Studies (3 papers), Lung Cancer Research Studies (3 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Toxicology (109 citations), Oncology (494 citations), Cancer Research (170 citations), Pathology and Forensic Medicine (190 citations) and Molecular Biology (606 citations). Ryan Bender has collaborated with scholars based in United States, Bosnia and Herzegovina and Italy. Frequent co-authors include Neil Osheroff, Zoran Gatalica, Sherri Z. Millis, R. Hunter Lindsey, Semir Vranić, Gargi D. Basu, Andreas Voß, Jennifer A. Wargo, Gerald C. Chu and Lawrence N. Kwong. Their work appears in journals such as Journal of Clinical Oncology, Biochemistry, Oncotarget, Human Pathology and Chemical Research in Toxicology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact